‘Too early’ to say if Airbus A220/CSeries Composite Wing Intellectual Property rights will be sold with Bombardier’s Belfast operations
Technology developed in Belfast for CSeries aircraft considered to be key issue in any sale
Click Like to Follow Fliegerfaust Facebook page to get the News ASAP / Share to share this post now.
May 7, 2019 - by Francess McDonnell for irishtimes.com
Bombardier's Belfast operation, Short Brothers plc, currently holds the valuable intellectual property (IP) rights to the pioneering technology it developed to manufacture the advanced composite wings for the CSeries aircraft, now the Airbus A220, the Canadian group has confirmed.
The IP rights to the unique resin transfer infusion process that was developed by Belfast engineers is considered by industry analysts to be a key issue in the sale of Bombardier's Northern Ireland operations.
However, Bombardier has not disclosed if it plans to strip ownership of the IP rights of the resin transfer infusion process from its Northern Ireland operations as part of the sale process.
The Canadian group said it was "too early" to discuss what would or would not be included in the sale of its Northern Ireland operations to a potential new owner...